3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
23
Lymphoma
16
Osteosarcoma
11
Lymphoma, Large B-Cell, Diffuse
11
Hodgkin Disease
11
Testicular Neoplasms
10
Lymphoma, Non-Hodgkin
10
Teratoma
8
Ovarian Neoplasms
7
Testicular Germ Cell Tumor
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Neoplasms
6
Burkitt Lymphoma
6
Recurrence
5
Endodermal Sinus Tumor
5
Central Nervous System Neoplasms
5
Carcinoma, Embryonal
5
Lymphoma, Large-Cell, Anaplastic
4
Seminoma
3
Rhabdomyosarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Germ Cell Cancer
3
Neurofibrosarcoma
3
Lymphoma, Mantle-Cell
3
Lymphoma, B-Cell
3
Histiocytoma, Malignant Fibrous
3
Fibrosarcoma
3
Vomiting
2
Sarcoma, Synovial
2
Sarcoma, Alveolar Soft Part
2
Interventions
Nivolumab
11
Ipilimumab
6
linrodostat
4
relatlimab
3
Pemetrexed
2
tislelizumab
1
regorafenib
1
ralimetinib
1
p38 Mitogen-Activated Protein Kinases
1
mirdametinib
1
gedatolisib
1
figitumumab
1
efatutazone
1
abemaciclib
1
Vorinostat
1
Tetanus Toxoid
1
Tamoxifen
1
Sunitinib
1
Ranitidine
1
Midazolam
1
LY2603618
1
LY2584702
1
Irinotecan
1
Gemcitabine
1
Fulvestrant
1
Dasatinib
1
Cyclophosphamide
1
Crizotinib
1
Cetuximab
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Advanced Cancer
×
Ifosfamide
×
Clear all
No trials found.